Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 01, 2015 06:30 ET | Source: RestorGenex

RestorGenex to Present at the Annual LD Micro Invitational Conference

BUFFALO GROVE, Ill., June 1, 2015 (GLOBE NEWSWIRE) -- RestorGenex Corporation (OTCQB:RESX), a specialty biopharmaceutical company focused on developing products for oncology, ophthalmology and...
May 21, 2015 06:00 ET | Source: RestorGenex

RestorGenex Announces Data on the Effect of RES-529 in Pulmonary Fibrosis Models

BUFFALO GROVE, Ill., May 21, 2015 (GLOBE NEWSWIRE) -- RestorGenex Corporation (OTCQB:RESX), a specialty biopharmaceutical company focused on developing products for oncology, ophthalmology and...
May 20, 2015 16:00 ET | Source: RestorGenex

RestorGenex to Present at Two Investor Conferences

BUFFALO GROVE, Ill., May 20, 2015 (GLOBE NEWSWIRE) -- RestorGenex Corporation (OTCQB:RESX), a specialty biopharmaceutical company focused on developing products for oncology, ophthalmology and...
May 11, 2015 16:05 ET | Source: RestorGenex

RestorGenex Reports First Quarter 2015 Financial Results

BUFFALO GROVE, Ill., May 11, 2015 (GLOBE NEWSWIRE) -- RestorGenex Corporation (OTCQB:RESX), a specialty biopharmaceutical company focused on developing products for oncology, ophthalmology and...
April 23, 2015 07:00 ET | Source: RestorGenex

RestorGenex Issues Annual Letter to Stockholders

BUFFALO GROVE, Ill., April 23, 2015 (GLOBE NEWSWIRE) -- RestorGenex Corporation (OTCQB:RESX), a specialty biopharmaceutical company focused on developing products for oncology, ophthalmology and...
April 06, 2015 07:00 ET | Source: RestorGenex

RestorGenex Reports Corporate Highlights and Financial Results for 2014

BUFFALO GROVE, Ill., April 6, 2015 (GLOBE NEWSWIRE) -- RestorGenex Corporation (OTCQB:RESX), a specialty biopharmaceutical company focused on developing products for oncology, ophthalmology and...
March 24, 2015 07:00 ET | Source: RestorGenex

RestorGenex CEO Featured in Equities.com Interview

BUFFALO GROVE, Ill., March 24, 2015 (GLOBE NEWSWIRE) -- RestorGenex Corporation (OTCQB:RESX), a specialty biopharmaceutical company focused on developing products for oncology, ophthalmology and...
March 18, 2015 07:00 ET | Source: RestorGenex

RestorGenex to Present at the Future Leaders in the Biotech Industry Conference

BUFFALO GROVE, Ill., March 18, 2015 (GLOBE NEWSWIRE) -- RestorGenex Corporation (OTCQB:RESX), a specialty biopharmaceutical company focused on developing products for oncology, ophthalmology and...
March 05, 2015 07:00 ET | Source: RestorGenex

RestorGenex to Present at the 27th Annual ROTH Conference

BUFFALO GROVE, Ill., March 5, 2015 (GLOBE NEWSWIRE) -- RestorGenex Corporation (OTCQB:RESX), a specialty biopharmaceutical company focused on developing products for oncology, ophthalmology and...
February 04, 2015 06:30 ET | Source: RestorGenex

RestorGenex to Present at BIO CEO & Investor Conference

BUFFALO GROVE, Ill., Feb. 4, 2015 (GLOBE NEWSWIRE) -- RestorGenex Corporation (OTCQB:RESX), a specialty biopharmaceutical company focused on developing products for ophthalmology, oncology and...